Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.093 | 0.002 |
mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.002 |
mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.003 |
mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.003 |
mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.003 |
mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.099 | 0.004 |
mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.004 |
mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.091 | 0.005 |